Malignant melanoma: clinical variants and prognostic indicators (Q34067612)

30 July 2017

1 reference

title

Malignant melanoma: clinical variants and prognostic indicators (English)

1 reference

30 July 2017

MacKie RM

1

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Clinical and Experimental Dermatology

30 July 2017

published in

1 reference

30 July 2017

volume

25

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

471-475

1 reference

Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Age as a prognostic factor in the malignant melanoma population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

The regressing thin malignant melanoma: a distinctive lesion with metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

Regression in malignant melanoma. A histologic feature without independent prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00692.X

10.1046/J.1365-2230.2000.00692.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference